首页|m6A甲基化修饰在胰腺癌中的研究进展

m6A甲基化修饰在胰腺癌中的研究进展

扫码查看
N6-甲基腺苷(N6-methyladenosine,m6A)作为真核生物 RNA中最丰富的表观转录组修饰,通过转移、去除和识别 m6A 甲基化位点来调节 RNA加工、剪接、成核、翻译和稳定性,而这些位点对于肿瘤的发生、进展、代谢和转移至关重要.胰腺癌是一种恶性程度较高的肿瘤,具有诊断晚、转移早、预后差、易耐药、缺乏有效治疗手段等特点,已成为临床治疗的一个巨大挑战.最近有研究发现,m6A修饰异常与胰腺癌的致病机制和恶性进展有关,因此,本文就 m6A 甲基化及其相关调节因子的异常表达在胰腺癌发生发展及治疗中的调控机制作一简要综述,旨在为胰腺癌的改进治疗和开创新疗法提供新思路.
Research progress of m6A methylation modification in pancreatic cancer
As the most abundant apparent transcriptome modification in eukaryotic RNA,N6-methyladenosine(m6A)regulates RNA processing,splicing,nucleation,translation and stability by transferring,removing and identif-ying m6A methylation sites,which are essential for tumorigenesis,progression,metabolism and metastasis.Pancreatic cancer is a highly malignant tumor,which has the characteristics of late diagnosis,early metastasis,poor prognosis,drug resistance and lack of effective treatment,which has become a great challenge to clinical treatment.Recently,it has been found that abnormal m6A modification is related to the pathogenesis and malignant progression of pancreatic cancer.Therefore,this article briefly reviewed the regulatory mechanism of the abnormal expression of m6A methylation and its related regulators in the occurrence,development and treatment of pancreatic cancer,in order to provide new ideas for improved treatment and new treatment of pancreatic cancer.

m6A methylationPancreatic cancerMechanismTreatmentProgress

郑立婷、陈嘉屿、陈玉春、李初谊、蒋觐阳、张久聪、于晓辉

展开 >

中国人民解放军联勤保障部队第九四〇医院消化内科,甘肃 兰州 730050

甘肃中医药大学第一临床医学院

中国人民解放军联勤保障部队第九四〇医院审核监管科

m6A甲基化 胰腺癌 机制 治疗 进展

甘肃省非感染性肝病临床医学研究中心甘肃省消化系统重症疾病临床医学研究中心

21JR7RA01721JR10RA017

2024

胃肠病学和肝病学杂志
郑州大学

胃肠病学和肝病学杂志

CSTPCD
影响因子:1.029
ISSN:1006-5709
年,卷(期):2024.33(1)
  • 1